Explore FHI 360

Published research

“Men can take part”: Examining men’s role in supporting self-injectable contraception in southern Malawi, a qualitative exploration

Feature

Partnering for greater equity and impact

FHI 360's partners based in the Pacific Islands, Malawi and India explore ways of breaking down power dynamics to achieve greater equity and impact — a theme of the GenderPlus Summit.

Published research

Turned away and at risk: Denial of family planning services to women in Malawi

Published research

The provider role and perspective in the denial of family planning services to women in Malawi: A mixed-methods study

Publication

Evidence and Strategies for Adolescent Girls' Education Programming: A Business Brief

This brief highlights the critical importance of educating adolescent girls, drawing on the latest evidence and FHI 360’s experience navigating the challenges that these girls face in attending school.

Published research

Young women's experiences with subcutaneous depot medroxyprogesterone acetate: A secondary analysis of a one-year randomized trial in Malawi

Published research

Factors affecting continued use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC): A secondary analysis of a 1-year randomized trial in Malawi

This paper assessed supply and demand factors that influence the use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC). The data show that continuation did not seem to be influenced by women's sociodemographic characteristics or the type of provider that trained the client to self-inject, whether clinic-based provider or community health worker. The results show that public-sector community health workers in low-resource settings can safely and effectively provide DMPA-SC and train women to self-inject the method.

Published research

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial

The authors found that women who self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) led to a more than 50 percent increase in pregnancy protection through 12 months compared with provider-administered injection. The findings demonstrate that self-injection can address the stubborn problem of early contraceptive discontinuation and that community health workers can safely train women to self-inject. Malawi plans to introduce DMPA-SC self-injection based on these positive findings.

Feature

DREAMS Innovation Challenge inspires girls to dream big

The DREAMS Innovation Challenge inspires one young woman in Malawi to pursue her education and dream about a future as an engineer.

News

PEPFAR names FHI 360 Malawi project as a winner of the DREAMS Innovation Challenge

The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) named FHI 360 a winner of the DREAMS Innovation Challenge for the Communities Investing in Education for Child Health and Safety project.

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

“Men can take part”: Examining men’s role in supporting self-injectable contraception in southern Malawi, a qualitative exploration

Partnering for greater equity and impact

Turned away and at risk: Denial of family planning services to women in Malawi

The provider role and perspective in the denial of family planning services to women in Malawi: A mixed-methods study

Evidence and Strategies for Adolescent Girls' Education Programming: A Business Brief

Young women's experiences with subcutaneous depot medroxyprogesterone acetate: A secondary analysis of a one-year randomized trial in Malawi

Factors affecting continued use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC): A secondary analysis of a 1-year randomized trial in Malawi

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial

DREAMS Innovation Challenge inspires girls to dream big

PEPFAR names FHI 360 Malawi project as a winner of the DREAMS Innovation Challenge

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Search within these results

13 Results Found

Factors affecting continued use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC): A secondary analysis of a 1-year randomized trial in Malawi

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial